Major Players - Spinal Cord Injury Therapeutics Industry

 

Spinal cord injuries are the injuries caused to the thirty one pairs of spinal nerves, which carry nerve signals from brain to various parts of the body and also controls the arm and leg movements. The main cause of spinal cord injuries include trauma, loss of blood supply to spinal cord, and compression in spinal cord due to tumor or infections. Spinal cord injuries can be diagnosed with the help of various techniques such as X-ray, magnetic resonance index (MRI), and computed tomography (CT).

The global Spinal Cord Injury Therapeutics Market is predicted to be valued at US$ 6,784.2 million in 2021, with a CAGR of 5.1% between 2021 and 2028.

Leading Companies in the Spinal Cord Injury Therapeutics Industry:

Teva Pharmaceutical Industries Ltd.:

1. Based in Israel, Teva Pharmaceutical Industries Ltd. develops, produces, markets, and distributes generic drugs, novel pharmaceuticals, and biopharmaceuticals along with its subsidiaries and affiliated businesses. Built in 1901. Teva Pharmaceutical Industries successfully sold Marksans Pharma their production site in Goa, India, for an undisclosed sum.

AbbVie Inc.:

2.   Pharmaceutical Company AbbVie, which was spun off from Abbott in early 2013, has a significant exposure to immunology and oncology, and its top product, Humira, accounts for nearly half of its current profits. The company's recent acquisition of Allergan adds several new drugs in the fields of women's health and aesthetics.

Pfizer Inc.:

3.    Pfizer Inc. is a pharmaceutical and biotechnology company based in America. It was founded in the year 1849. Pfizer manufactures and produces vaccines and medicine related to oncology, neurology, cardiology, and immunology. The corporation has produced various products that yield more than US$1 billion in annual revenue. The company ranked 64^th on the Fortune 500 and 49^th on the Forbes Global 2000. The headquarters are located in New York City, U.S. and the products manufactured are sold worldwide. The company was founded by Charles Pfizer and Charles F. Erhart.  In 2022, the company acquired Arena Pharmaceuticals for US$ 6.7 Billion. In October 2022, Pfizer completed the acquisition Biohaven Pharma for US$ 11.6 Billion.

Dr. Reddy's Laboratories Ltd.:

4. Established in 1984. Dr. Reddy's Laboratories is an Indian company with global operations that develops and produces generic pharmaceuticals. The business specialises in active pharmaceutical ingredients and low-cost, easily manufactured small-molecule generic medications. The most recent acquisitions are Habitrol (Dec 2014), Nimbus Health (Feb 2022), and Cidmus (Apr 2022).

Zydus Cadila:

5.    Established in 2005. United States headquarters.Manufacturer and distributor of pharmaceutical goods and chemicals that support patients' efforts to treat and manage illnesses, combat infections, and enhance their general well-being. The company provides patients with top-notch healthcare solutions that enable them to live healthier and more fulfilling lives by providing calcium pills, salt injections, ointments, dinitrate tablets, paricalcitol capsules, and more.

ReNetX Bio, Inc.:

6.    Disease-modifying medicines are being developed to treat spinal cord damage, stroke recovery, and Alzheimer's disease. The therapies offered by the company are small molecule oral medications that prevent the binding of -amyloid (A) oligomers to PrP in the brain, allowing patients with central nervous system problems to receive adequate treatment by encouraging axon regrowth. Established in 2010. Headquarters are in the United States. ReNetX Bio, Inc. Receives FDA Approval to Move Forward with IND Application to Treat Patients with Chronic Spinal Cord Injury.

InVivo Therapeutics Holdings:

7.    InVivo Therapeutics Holdings Corp is a biomaterials and biotechnology firm in the research and clinical stages. It is concerned with the treatment of spinal cord injuries. Neuro spinal scaffold and Bioengineered neural trails are among the products in the company's pipeline. The company has a preclinical research programme for chronic spinal cord damage as well as a clinical development programme for acute spinal cord injury. Established in 2005. Headquarters are in the United States.

*Definition:

A spinal cord injury (SCI) is damage to the tight bundle of cells and nerves that sends and receives signals from the brain to and from the rest of the body.